News | September 16, 2009

Premion First in Australia to Treat Cancer Patients with RapidArc

September 16, 2009 - Cancer patients in Australia have gained access to advanced RapidArc radiotherapy treatments from Varian Medical Systems with its introduction by the leading radiation oncology provider in Queensland.

Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.

Dr. James MacKean, Premion's lead radiation oncologist for the RapidArc program, said, "With RapidArc, improved conformality and daily treatment set-up accuracy is combined with dynamic rotational arc treatments, keeping unwanted radiation doses away from nearby structures such as the rectum and bladder. Treatment times are reduced, which improves the overall patient experience."

"RapidArc, which we introduced after extensive testing, is combined with the latest generation Varian treatment machine incorporating advanced image-guidance technology,'' explained senior medical physicist Matthew Murray. "At Premion we have a great team of dedicated radiation therapists and medical physicists to ensure these advanced treatment techniques are delivered to the highest standards."

Premion, which treats cancer patients using ten linear accelerators at its five sites, says its RapidArc program at Chermside will expand to include the treatment of brain, head and neck and lung tumors in the near future.

Premion patient, 68-year-old Bob Major, received RapidArc treatment over an eight week period in July and August. "I found my treatment on the RapidArc-equipped machine excellent, I was in and out of the treatment room in minutes, the Premion staff were very professional and my urologist worked closely with Dr. MacKean to develop my treatment plan," he said.

RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and makes it possible to deliver image-guided intensity modulated radiotherapy (IMRT) two to eight times faster than is possible with conventional IMRT. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery and, with less time on the treatment couch, also allow for greater patient comfort. Conventional IMRT treatments are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.

"The philosophy of Premion at all five of our locations is to offer Queensland and northern New South Wales patients the full range of state-of-the-art facilities in a friendly, efficient and caring environment," indicated Dr. MacKean. "'We strive to avoid waiting lists and improve patient access."

Stuart Hamilton, Varian's regional sales director, added, "Premion is continually striving to offer more advanced treatments for the benefit of cancer patients and we are delighted to be working with Premion to introduce RapidArc in Australia. Since the introduction of the technique in the US and Europe last year, more than 100 cancer centers worldwide have introduced this approach, improving the patient experience while maximizing treatment precision."

For more information: www.varian.com

Related Content

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Overlay Init